Healthcare -
Biotechnology - NASDAQ - CN
$ 1.6001
-1.85 %
$ 60.3 M
Market Cap
-2.15
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Adagene Inc.
| Revenue | 103 K |
| Cost Of Revenue | 926 K |
| Gross Profit | -823 K |
| Operating Expenses | 36.1 M |
| Operating Income | -36 M |
| Other Expenses | -2.53 M |
| Net Income | -33.4 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Revenue | 0.1 | 18.1 | 9.3 | 10.2 | 0.5 | 0.5 | 1.5 |
| GROSS PROFIT | |||||||
| Cost Of Revenue | 0.9 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | (0.8) | 18.1 | 9.3 | 10.2 | 0.5 | 0.5 | 1.5 |
| OPERATING INCOME | |||||||
| Operating Expenses | 36.1 | 41.8 | 93.2 | 82.5 | 19.6 | 19.6 | 18.8 |
| Selling, General and Administrative Expenses | 7.3 | 8.7 | 11.9 | 14.4 | 3.4 | 3.4 | 2.8 |
| Research and Development Expenses | 27.9 | 36.6 | 81.3 | 68.1 | 16.2 | 16.2 | 16.1 |
| Operating Income | (36.0) | (23.7) | (83.9) | (72.4) | (19.2) | (19.2) | (17.3) |
| PRE-TAX INCOME | |||||||
| Interest Income Expense | 0.9 | 1.1 | 0.7 | 0.4 | 0.1 | 0.1 | 91.1 K |
| Total Other Income | 2.5 | 6.5 | 4.4 | 0.9 | 0.8 | 2.7 | 2.1 |
| Pre-Tax Income | (33.4) | (17.3) | (79.5) | (71.5) | (16.4) | (16.4) | (15.3) |
| NET INCOME | |||||||
| Tax Provision | 17.6 K | 1.7 | 0.5 | 1.7 | 3.16 K | 0.9 | (0.5) |
| Net Income | (33.4) | (18.9) | (80.0) | (73.2) | (16.4) | (17.3) | (14.7) |
| EPS | 0.95 | 0.55 | 2.31 | 2.29 | 0.59 | 0.49 | 0.54 |